{"organizations": [], "uuid": "8d161b2cc14671f407252ffaa13afb183ab73564", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180329.html", "section_title": "Archive News &amp; Video for Thursday, 29 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-acerus-pharmaceuticals-corp-appoin/brief-acerus-pharmaceuticals-corp-appointed-edward-gudaitis-ceo-idUSFWN1RB0KE", "country": "US", "domain_rank": 408, "title": "Acerus Pharmaceuticals Corp Appointed Edward Gudaitis CEO", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-29T20:38:00.000+03:00", "replies_count": 0, "uuid": "8d161b2cc14671f407252ffaa13afb183ab73564"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-acerus-pharmaceuticals-corp-appoin/brief-acerus-pharmaceuticals-corp-appointed-edward-gudaitis-ceo-idUSFWN1RB0KE", "ord_in_thread": 0, "title": "Acerus Pharmaceuticals Corp Appointed Edward Gudaitis CEO", "locations": [], "entities": {"persons": [{"name": "edward gudaitis", "sentiment": "negative"}, {"name": "gudaitis", "sentiment": "none"}, {"name": "luc mainville", "sentiment": "none"}], "locations": [], "organizations": [{"name": "acerus pharmaceuticals corporation", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "acerus pharmaceuticals corp", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 29 (Reuters) - Acerus Pharmaceuticals Corporation :\n* ACERUS PHARMACEUTICALS CORPORATION - ‍APPOINTED EDWARD GUDAITIS AS PRESIDENT AND CHIEF EXECUTIVE OFFICER​\n* ACERUS PHARMACEUTICALS CORPORATION - LUC MAINVILLE WILL CONTINUE TO ACT AS INTERIM CEO, WILL WORK WITH GUDAITIS TO ENSURE SMOOTH TRANSITION Source text for Eikon: Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-03-29T20:38:00.000+03:00", "crawled": "2018-03-30T12:56:10.013+03:00", "highlightTitle": ""}